Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2013 by Jiangsu HengRui Medicine Co., Ltd..
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Jiangsu HengRui Medicine Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01970059
First received: October 22, 2013
Last updated: NA
Last verified: October 2013
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)